Exploring the role of the inflammasomes on prostate cancer: Interplay with obesity
- PMID: 37819510
- PMCID: PMC10697898
- DOI: 10.1007/s11154-023-09838-w
Exploring the role of the inflammasomes on prostate cancer: Interplay with obesity
Abstract
Obesity is a weight-related disorder characterized by excessive adipose tissue growth and dysfunction which leads to the onset of a systemic chronic low-grade inflammatory state. Likewise, inflammation is considered a classic cancer hallmark affecting several steps of carcinogenesis and tumor progression. In this regard, novel molecular complexes termed inflammasomes have been identified which are able to react to a wide spectrum of insults, impacting several metabolic-related disorders, but their contribution to cancer biology remains unclear. In this context, prostate cancer (PCa) has a markedly inflammatory component, and patients frequently are elderly individuals who exhibit weight-related disorders, being obesity the most prevalent condition. Therefore, inflammation, and specifically, inflammasome complexes, could be crucial players in the interplay between PCa and metabolic disorders. In this review, we will: 1) discuss the potential role of each inflammasome component (sensor, molecular adaptor, and targets) in PCa pathophysiology, placing special emphasis on IL-1β/NF-kB pathway and ROS and hypoxia influence; 2) explore the association between inflammasomes and obesity, and how these molecular complexes could act as the cornerstone between the obesity and PCa; and, 3) compile current clinical trials regarding inflammasome targeting, providing some insights about their potential use in the clinical practice.
Keywords: Adipose tissue; IL-1β; Inflammasome; NF-κB; Obesity; Prostate cancer.
© 2023. The Author(s).
Conflict of interest statement
The authors have no financial interests to disclose.
Figures
Similar articles
-
NLRP3 Inflammasome: A Possible Link Between Obesity-Associated Low-Grade Chronic Inflammation and Colorectal Cancer Development.Front Immunol. 2018 Dec 11;9:2918. doi: 10.3389/fimmu.2018.02918. eCollection 2018. Front Immunol. 2018. PMID: 30619282 Free PMC article. Review.
-
Hydrogen-Rich Saline Attenuated Subarachnoid Hemorrhage-Induced Early Brain Injury in Rats by Suppressing Inflammatory Response: Possible Involvement of NF-κB Pathway and NLRP3 Inflammasome.Mol Neurobiol. 2016 Jul;53(5):3462-3476. doi: 10.1007/s12035-015-9242-y. Epub 2015 Jun 20. Mol Neurobiol. 2016. PMID: 26091790
-
Calcium-sensing receptor activates the NLRP3 inflammasome in LS14 preadipocytes mediated by ERK1/2 signaling.J Cell Physiol. 2018 Aug;233(8):6232-6240. doi: 10.1002/jcp.26490. Epub 2018 Mar 9. J Cell Physiol. 2018. PMID: 29345311
-
Activation of the Adipose Tissue NLRP3 Inflammasome Pathway in Cancer Cachexia.Front Immunol. 2021 Sep 23;12:729182. doi: 10.3389/fimmu.2021.729182. eCollection 2021. Front Immunol. 2021. PMID: 34630405 Free PMC article.
-
New Insights Into the Interplay Among Autophagy, the NLRP3 Inflammasome and Inflammation in Adipose Tissue.Front Endocrinol (Lausanne). 2022 Mar 31;13:739882. doi: 10.3389/fendo.2022.739882. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35432210 Free PMC article. Review.
Cited by
-
The Protective Effects of an Aged Black Garlic Water Extract on the Prostate.Nutrients. 2024 Sep 7;16(17):3025. doi: 10.3390/nu16173025. Nutrients. 2024. PMID: 39275340 Free PMC article.
-
Association between the serum uric acid levels and prostate cancer: evidence from National Health and Nutrition Examination Survey (NHANES) 1999-2010.Transl Cancer Res. 2024 May 31;13(5):2308-2314. doi: 10.21037/tcr-24-46. Epub 2024 May 22. Transl Cancer Res. 2024. PMID: 38881930 Free PMC article.
References
-
- Eeles RA, Dearnaley DP, ArdernJones A, Shearer RJ, Easton DF, Ford D, Edwards S, Dowe A, Anderson J, Archibold J, Bailey M, Barker C, Bellringer J, Bishop DT, Bishop M, Bolger J, Boyd J, Budd D, Butler M, Brookstein R, Charig C, Conn I, Cranston C, Crundwell M, Das G, Doble A, Duncan W, Duchesne J, Eccles D, Fawcett D, Fisher C, Fletcher M, Fowler JW, Gallegos C, Ghaznavi A, Gilbert H, Glaholm J, Gordon E, Hampson S, Hanbury DC, Hargreave T, Harland S, Harrison GS, Harrison NW, Hart JL, Hehir M, Hendry W, Higgins A, Hopper J, Horwich A, Hughes M, Irving S, James N, Jenkins IL, Jones C, Key T, Kaisary A, Kirby R, Kirk D, Lee J, Lemberger R, Lloyd S, Lynch M, Malone PR, Mansi J, Mason M, McEwan AB, McNicholas TA, Moffat LEF, Morgan RJ, Murday V, Muir G, Munson KW, Murray K, Murrell S, Newman H, Oboyle PJ, Odonoghue E, Notley RG, Pengelly A, Philip T, Plail R, Powell C, Russell J, Read G, Reddy PJ, Richmond W, Roberts T, Rowley K, Rouse AD, Russell RM, Ryan P, Senanayake L, Sandhu D, Shridhar P, Shweitzer R, Shearer R, Smith J, Smith P, Stockdale A, Stower M, Thomas P, Terry T, Thurston A, Tullock D, Turner G, Wallace M, Weston P, Whelan P, Whillis D, Wilson R, Williams G, Woodhouse C. Familial prostate cancer: The evidence and the Cancer Research Campaign British Prostate Group (CRC/BPG) UK Familial Prostate Cancer Study. Br J Urol. 1997;79:8–14. doi: 10.1111/j.1464-410X.1997.tb00795.x. - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical